Abstract: A method is provided for inhibiting the .gamma. to .beta.-globin switching in subjects afflicted with .beta.-globin disorders. The method is particularly adapted for ameliorating the clinical symptoms of sickle cell anemia by periodically introducing butyrate, .Iadd..alpha.-amino-n-butyric acid, .Iaddend.or .?.certain isomers, homologs, analogs or chemical variations thereof,.!. .Iadd.isobutyramide .Iaddend.into the bloodstream of the subject prior to natural completion of the switching process.
Type:
Grant
Filed:
June 18, 1993
Date of Patent:
February 2, 1999
Assignee:
Children's Hospital Medical Center of Northern California